Letters
Author Affiliation: Vanderbilt University Medical Center, Nashville, Tennessee. Corresponding Author: Ellen Wright Clayton, MD, JD, Vanderbilt University Medical Center, 2525 West End Ave, Nashville, TN 37203 ([email protected]). Conflict of Interest Disclosures: The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported being the chair of the IOM Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 1. Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. http://www.iom.edu/Reports/2015/ME-CFS .aspx. Accessed May 13, 2015.
CORRECTION Data Errors in Results Section: In the Original Contribution entitled “Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure: The FOCUS-CCTRN Trial” published in the April 25, 2012, issue of JAMA (2012; 307[16]:1717-1726. doi:10.1001/jama.2012.418), there were data errors in the Results section. In the last paragraph of the Results section, the penultimate sentence should be “Six patients (2 in the BMC group and 4 in the placebo group) were rehospitalized for congestive heart failure, with 1 patient in the BMC group hospitalized for acute coronary syndrome during this same time frame.” This article was corrected online. Data Errors in Table 3 and in Text: In the Preliminary Communication entitled “Effect on Left Ventricular Function of the Use and Timing of Bone Marrow Mononuclear Cell Delivery After Acute Myocardial Infarction: The TIME Randomized Trial” published in the December 12, 2012, issue of JAMA (2012; 308[22]:2380-2389. doi:10.1001/jama.2012.28726), there was 1 data error in the text and data errors in Table 3. In the Results section, paragraph 5, third sentence, “Eleven” should be “Ten”; therefore, the full sentence should be “Ten patients underwent repeat revascularization and 6 received implantable cardioverter-defibrillators.” In Table 3, row 1, “Patients, No. (%),” column 2 should be “14 (18)” and column 4 should be “21 (18).” In row 10, “Crude incidence rate,” column 2 should be “0.177” and column 4 should be “0.175.” In row 11, “Relative risk (95% CI) for BMC vs placebo,” column 2 should be “0.97 (0.422.20).” This article was corrected online. Data Errors in Table 2: In the Research Letter entitled “One-Year Follow-up of Intracoronary Stem Cell Delivery on Left Ventricular Function Following ST-Elevation Myocardial Infarction” published in the January 15, 2014, issue of JAMA (2014;311[3]:301-302. doi:10.1001/jama.2013.282674), there were data errors. In Table 2, the heading “No. of Patientsa” should be “No. of Events” and footnote “a” should be removed from the footnote list. In row 1, column 1 should be “No. of patients with any event,” column 2 should be “17,” and column 3 should be “10.” In row 3, column 1, the footnote has changed with the elimina-
86
tion of footnote “a,” this row should be “Reinfarctiona” and in the footnote list, footnote “b” should be “a”; however, the footnote text remains unchanged. In row 4, column 1 should be “Repeat revascularizationb” and in the footnote list, footnote “c” should be “b”; however, the footnote text remains unchanged. In row 8, column 1 should be “ICD placementc” and in the footnote list, footnote “d” should be “c”; however, the footnote text remains unchanged. In the last row, “Proportion of patients with events,” the data for column 2 should be “0.215” and column 3 should be “0.244.” This article was corrected online. Incorrect Data in Table 4: In the Original Investigation entitled “Association Between Asthma and Risk of Developing Obstructive Sleep Apnea,” published in the January 13, 2015, issue of JAMA (2015;313[2]:156-164. doi:10.1001/jama .2014.17822), Table 4 contained incorrect data for the mean (95% CI) of the following 2 rows: apnea-hypopnea index at the end of the 8-year interval and change in body mass index over 8-year interval. This article was corrected online.
Guidelines for Letters Letters discussing a recent JAMA article should be submitted within 4 weeks of the article's publication in print. Letters received after 4 weeks will rarely be considered. Letters should not exceed 400 words of text and 5 references and may have no more than 3 authors. Letters reporting original research should not exceed 600 words of text and 6 references and may have no more than 7 authors. They may include up to 2 tables or figures but online supplementary material is not allowed. All letters should include a word count. Letters must not duplicate other material published or submitted for publication. Letters not meeting these specifications are generally not considered. Letters being considered for publication ordinarily will be sent to the authors of the JAMA article, who will be given the opportunity to reply. Letters will be published at the discretion of the editors and are subject to abridgement and editing. Further instructions can be found at http://jama.com/public /InstructionsForAuthors.aspx. A signed statement for authorship criteria and responsibility, financial disclosure, copyright transfer, and acknowledgment and the ICMJE Form for Disclosure of Potential Conflicts of Interest are required before publication. Letters should be submitted via the JAMA online submission and review system at http: //manuscripts.jama.com. For technical assistance, please contact [email protected]. Section Editor: Jody W. Zylke, MD, Deputy Editor.
JAMA July 7, 2015 Volume 314, Number 1 (Reprinted)
Copyright 2015 American Medical Association. All rights reserved.
Downloaded From: http://jama.jamanetwork.com/ on 08/07/2017
jama.com
Author Affiliation: Vanderbilt University Medical Center, Nashville, Tennessee. Corresponding Author: Ellen Wright Clayton, MD, JD, Vanderbilt University Medical Center, 2525 West End Ave, Nashville, TN 37203 ([email protected]). Conflict of Interest Disclosures: The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and reported being the chair of the IOM Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. 1. Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: redefining an illness. http://www.iom.edu/Reports/2015/ME-CFS .aspx. Accessed May 13, 2015.
CORRECTION Data Errors in Results Section: In the Original Contribution entitled “Effect of Transendocardial Delivery of Autologous Bone Marrow Mononuclear Cells on Functional Capacity, Left Ventricular Function, and Perfusion in Chronic Heart Failure: The FOCUS-CCTRN Trial” published in the April 25, 2012, issue of JAMA (2012; 307[16]:1717-1726. doi:10.1001/jama.2012.418), there were data errors in the Results section. In the last paragraph of the Results section, the penultimate sentence should be “Six patients (2 in the BMC group and 4 in the placebo group) were rehospitalized for congestive heart failure, with 1 patient in the BMC group hospitalized for acute coronary syndrome during this same time frame.” This article was corrected online. Data Errors in Table 3 and in Text: In the Preliminary Communication entitled “Effect on Left Ventricular Function of the Use and Timing of Bone Marrow Mononuclear Cell Delivery After Acute Myocardial Infarction: The TIME Randomized Trial” published in the December 12, 2012, issue of JAMA (2012; 308[22]:2380-2389. doi:10.1001/jama.2012.28726), there was 1 data error in the text and data errors in Table 3. In the Results section, paragraph 5, third sentence, “Eleven” should be “Ten”; therefore, the full sentence should be “Ten patients underwent repeat revascularization and 6 received implantable cardioverter-defibrillators.” In Table 3, row 1, “Patients, No. (%),” column 2 should be “14 (18)” and column 4 should be “21 (18).” In row 10, “Crude incidence rate,” column 2 should be “0.177” and column 4 should be “0.175.” In row 11, “Relative risk (95% CI) for BMC vs placebo,” column 2 should be “0.97 (0.422.20).” This article was corrected online. Data Errors in Table 2: In the Research Letter entitled “One-Year Follow-up of Intracoronary Stem Cell Delivery on Left Ventricular Function Following ST-Elevation Myocardial Infarction” published in the January 15, 2014, issue of JAMA (2014;311[3]:301-302. doi:10.1001/jama.2013.282674), there were data errors. In Table 2, the heading “No. of Patientsa” should be “No. of Events” and footnote “a” should be removed from the footnote list. In row 1, column 1 should be “No. of patients with any event,” column 2 should be “17,” and column 3 should be “10.” In row 3, column 1, the footnote has changed with the elimina-
86
tion of footnote “a,” this row should be “Reinfarctiona” and in the footnote list, footnote “b” should be “a”; however, the footnote text remains unchanged. In row 4, column 1 should be “Repeat revascularizationb” and in the footnote list, footnote “c” should be “b”; however, the footnote text remains unchanged. In row 8, column 1 should be “ICD placementc” and in the footnote list, footnote “d” should be “c”; however, the footnote text remains unchanged. In the last row, “Proportion of patients with events,” the data for column 2 should be “0.215” and column 3 should be “0.244.” This article was corrected online. Incorrect Data in Table 4: In the Original Investigation entitled “Association Between Asthma and Risk of Developing Obstructive Sleep Apnea,” published in the January 13, 2015, issue of JAMA (2015;313[2]:156-164. doi:10.1001/jama .2014.17822), Table 4 contained incorrect data for the mean (95% CI) of the following 2 rows: apnea-hypopnea index at the end of the 8-year interval and change in body mass index over 8-year interval. This article was corrected online.
Guidelines for Letters Letters discussing a recent JAMA article should be submitted within 4 weeks of the article's publication in print. Letters received after 4 weeks will rarely be considered. Letters should not exceed 400 words of text and 5 references and may have no more than 3 authors. Letters reporting original research should not exceed 600 words of text and 6 references and may have no more than 7 authors. They may include up to 2 tables or figures but online supplementary material is not allowed. All letters should include a word count. Letters must not duplicate other material published or submitted for publication. Letters not meeting these specifications are generally not considered. Letters being considered for publication ordinarily will be sent to the authors of the JAMA article, who will be given the opportunity to reply. Letters will be published at the discretion of the editors and are subject to abridgement and editing. Further instructions can be found at http://jama.com/public /InstructionsForAuthors.aspx. A signed statement for authorship criteria and responsibility, financial disclosure, copyright transfer, and acknowledgment and the ICMJE Form for Disclosure of Potential Conflicts of Interest are required before publication. Letters should be submitted via the JAMA online submission and review system at http: //manuscripts.jama.com. For technical assistance, please contact [email protected]. Section Editor: Jody W. Zylke, MD, Deputy Editor.
JAMA July 7, 2015 Volume 314, Number 1 (Reprinted)
Copyright 2015 American Medical Association. All rights reserved.
Downloaded From: http://jama.jamanetwork.com/ on 08/07/2017
jama.com
